Ethyl 4-((2,4-dimethylphenyl)(methoxycarbonyl)amino)butanoate, 98%, 250mg

N-Methyl-4-nitro-N-[2-(4-nitrophenoxy)ethyl]phenylethylamine>97.0%(GC)(T)1g

4,6-Di-tert-butylresorcinol>98.0%(GC)25g

3-(4-Hydroxy-2-methyl-quinolin-3-yl)-propionic acid, 95.0%, 250mg

5-Methyl-1-vinyl-1H-pyrazole-4-carbaldehyde, 95.0%, 5g

3-BROMO-8-(METHYLTHIO)IMIDAZO[1,2-A]PYRAZINE, 95.0%, 100mg

4-Methyl-3-nitropyridine, 98.0%, 1g

Acetoxyvalerenic acid, with analyt. Documents, 25 mg, glass packaging

3-Chloro-4-hydroxy-5-methoxy benzaldehyde, 98.0%, 5g

3-Oxetanecarboxylic acid, 90.0%, 250mg

3-BROMO-IMIDAZO[1,5-A]PYRIMIDINE-8-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 2g

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(S)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE, 95.0%, 100mg